Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 301
Careers in Clinical Research: Obstacles and Opportunities Appendix D Agenda for the Workshop on Clinical Research and Training: Spotlight on Funding June 12-13, 1992 Cecil and Ida Green Building Room 104 2001 Wisconsin Avenue, NW Washington, D.C. Friday, June 12 8:00 Registration and Coffee 8:30 Welcome and Introductions - Robert Collins, Workshop Chair 8:35 Committee Overview - William Kelley, Committee Chair 8:45 Keynote Address - James Wyngaarden, Duke University and National Academy of Sciences 9:15 FEDERAL SUPPORT FOR PATIENT-ORIENTED CLINICAL RESEARCH Discussion Leader: Mary Charlson 9:20 Overview of Federal Sponsorship of Patient-oriented Clinical Research - William Raub, White House Office of Science and Technology Policy
OCR for page 302
Careers in Clinical Research: Obstacles and Opportunities 9:45 Reactions from Federal Agencies - Darrell Regier, Director, Division of Clinical Research, NIMH - Dennis Smith, Associate Director for Medical Research, Department Veterans Affairs - Ira Raskin, Agency for Health Care Policy and Research 10:15 Panel/Committee Discussion 11:00 BREAK 11:15 PRIVATE SECTOR FUNDING Discussion Leader: Irving Fox 11:20 Funding by the Pharmaceutical/Biotechnology Industry - Louis Lasagna, Tufts University 11:30 University/Industry Cooperative Funding Ventures - Virginia Weldon, Monsanto Corporation 11:40 Nonprofit Sponsors - Thomas Langfitt, Pew Charitable Trusts 11:50 Panel/Committee Discussion 12:40 LUNCH 1:30 SHARING THE COSTS OF CLINICAL RESEARCH: I. THIRD-PARTY PAYERS Discussion Leader: Karen Antman 1:40 Role of Third-Party Payment Decisions on Clinical Research - Michael Friedman, National Cancer Institute 1:50 Blue Cross/Blue Shield - Ralph Schafferzick, Formerly with Blue Cross/Blue Shield of California 2:00 Private Insurers - James Mulvihill, Travelers Insurance Company 2:10 Health Maintenance Organizations - Robert Goodman, US HealthCare, Inc. 2:20 Panel/Committee Discussion
OCR for page 303
Careers in Clinical Research: Obstacles and Opportunities 3:15 BREAK 3:30 SHARING THE COSTS OF CLINICAL RESEARCH: II. HOSPITALS AND ACADEMIC HEALTH CENTERS Discussion Leader: William Kelley 3:35 NIH Intramural and Extramural Funding - John Diggs, Deputy Director for Extramural Research, NIH 3:45 Teaching Hospitals Jerome Grossman, New England Medical Center 3:55 Academic Health Centers - David Challoner, University of Florida 4:05 Hospital-Based Clinical Research - Ruth Hanft, The Geroge Washington University 4:15 A Clinical Investigator's Perspective - John Glick, University of Pennsylvania 4:25 Panel/Committee Discussion 5:15 Concluding Remarks by Rapporteur - Eli Ginzberg, Columbia University 5:30 Adjourn 5:30 RECEPTION AND DINNER Saturday, June 13 8:00 Continental Breakfast 8:30 FOCUS ON HUMAN RESOURCES Discussion Leader: John Stobo 8:30 Overview of Barriers to Careers in Clinical Research - John Stobo, Johns Hopkins University 8:45 Organizational Barriers (Medical Schools) - Alfred Fishmam, University of Pennsylvania
OCR for page 304
Careers in Clinical Research: Obstacles and Opportunities 9:00 Indebtedness - Congressional Perspective - Van Dunn, Senate Labor and Human Resources Committee 9:15 Indebtedness - Medical School's Perspective - Julie Disa, Johns Hopkins University 9:30 Panel/Committee Discussion 10:00 BREAK 10:15 FINANCING CLINICAL RESEARCH TRAINING Discussion Leader: Albert Mulley 10:15 NRSA Training - Charlotte Kuh, Educational Testing Service 10:30 American Cancer Society Program - Virgil Loeb, Washington University 10:45 Nonprofit Organizations - Richard Reynolds, Robert Wood Johnson Foundation 11:00 Medical Scientist Training Program - Harold Swartz, Dartmouth Medical School 11:15 Panel/Committee Discussion 11:45 Concluding Remarks by Rapporteur - E.H. Ahrens, Rockefeller University
Representative terms from entire chapter: